A review of how AI is being used in brain tumor care
Original title: AI in Neuro-Oncology: An Overarching Review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of where the science is heading, not a new result.
The short version
Experts looked at where AI stands today in brain tumor care.
What was studied. Working groups from RANO: Short for Response Assessment in Neuro-Oncology. An agreed set of rules for judging whether a tumor has changed. It uses the scan, your steroid dose, and how you are doing. See the glossary joined together to write this review. They looked at how AI is used across six key areas: brain scans, tumor tissue study, lab medicine, surgery, drug discovery, and clinical trials.
What they found. The uses closest to real care are in brain scans. AI can outline a tumor, measure it, and help make clearer scan pictures. It can also help sort tumors by DNA patterns and make hospital workflow smoother. Other uses, like guiding surgery or reading blood tests for tumor signs, still need more testing in people.
What this means, and what it doesn't
What it could mean: Some AI tools may already help your care team read scans or sort tumor samples. You may never see them working. They support your doctors, who still make the decisions.
What it doesn't mean: This is not a new treatment or a cure. It is a review of where the science stands, not a new study result. Many of the tools named here are not ready for everyday care. The authors say the tools need testing at more hospitals and in more diverse groups of people. They also say a person must always stay in charge of care.
Source: PubMed, October 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.